Treatment with trimethoprim-sulfamethoxazole (5 mg/kg p.o. every 6 h) was performed during 12 weeks with a good response. There was also a ...×Title(Title)MrMsDr.ProfessorFirstName*LastName*Company/InstitutionE-Mail*Message*indicatesrequiredfieldsThissiteisprotectedbyreCAPTCHAandtheGooglePrivacyPolicyandTermsofServiceapply.00×JournalsBooksCoursesCollectionsSubjectGuideLogin00JournalMenuJournalHomeAboutThisJournalGuidelinesJournalContactAboutOpenAccessContents:allyears×CaseReportsinNeurologyDownloadFulltextPDFPublished:January2015BrainAbscessduetoStaphylococcuslugdunensisintheAbsenceofEndocarditisorBacteremiaMatasA.·VeigaA.·GabrielJ.P.AuthoraffiliationsCentroHospitalarTrás-os-Montes-e-Alto-Douro,VilaReal,PortugalCorrespondingAuthorDr.AndreiaMatasCentroHospitalarTrás-os-Montes-e-Alto-DouroAv.Noruega,LordeloPT-5000-508VilaReal(Portugal)[email protected]:StaphylococcuslugdunensisBrainabscessCoagulase-negativestaphylococcusRelatedArticlesfor""CaseRepNeurol2015;7:1-5https://doi.org/10.1159/000371441AbstractFullTextPDFReferencesExtras:3AbstractStaphylococcuslugdunensishasbeenrecognizedtobeamicroorganismpotentiallymorevirulentthanothercoagulase-negativestaphylococci.Wereportthecaseofapatientwhopresentedwithasingle,large,right,frontoparietalabscessthatevolveddespiteconventionalantibiotictreatment.Bacteremiaandendocarditiswereexcluded.Aftersurgicaltreatment,S.lugdunensissensibletotrimethoprim-sulfamethoxazolewasisolated,andthepatientrespondedfavorablytotreatment.AlthoughtheabilityofS.lugdunensistoproducebrainabscesseshasbeenrecognized,wereportacaseofabrainabscessintheabsenceofbacteremiaorendocarditis.©2015S.KargerAG,BaselIntroductionStaphylococcuslugdunensis,oneofthecoagulase-negativestaphylococci,wasfirstdescribedbyFreneyetal.[1]in1988.Whileoriginallythoughttobeaskincommensalrarelyresponsibleforopportunisticinfection,itwasrapidlyestablishedasasignificanthumanpathogenandisnowrecognizedtobeamicroorganismpotentiallymorevirulentthanothercoagulase-negativest